Victory Capital to Move Headquarters to San Antonio, Texas
New Location Supports Future Growth and Expands Pools of Talent CLEVELAND, Jan. 10, 2019 (GLOBE NEWSWIRE) — Victory Capital (NASDAQ: […]
IMPROVING THE PASSENGER EXPERIENCE ONBOARD LUXURY BUSES AND MOTORCOACHES WITH ELECTRONICALLY DIMMABLE WINDOWS USING RESEARCH FRONTIERS SPD-SMARTGLASS TECHNOLOGY
This week, Research Frontiers licensee Vision Systems showcasing SPD- SmartGlass EDW solutions at UMA Motorcoach Expo 2019 in Ft. Lauderdale, Florida. […]
LPL Financial Welcomes Harbor Financial Group
CHARLOTTE, N.C., Jan. 10, 2019 (GLOBE NEWSWIRE) — LPL Financial LLC, a leading retail investment advisory firm and independent broker-dealer, […]
First Merchants Corporation to Report Fourth Quarter 2018 Financial Results, Host Conference Call and Webcast
MUNCIE, Ind., Jan. 10, 2019 (GLOBE NEWSWIRE) — First Merchants Corporation (Nasdaq:FRME) will report fourth quarter 2018 financial results on […]
American Airlines Group Announces Webcast of Fourth Quarter 2018 Financial Results
FORT WORTH, Texas, Jan. 10, 2019 (GLOBE NEWSWIRE) — American Airlines Group (NASDAQ: AAL) will webcast a live audio feed […]
Legacy Housing Corporation Adds Analyst Coverage (Nasdaq:LEGH)
DALLAS, Jan. 10, 2019 (GLOBE NEWSWIRE) — Legacy Housing Corporation (NASDAQ: LEGH), the fourth largest producer of manufactured homes in […]
FCA US Reaches Settlements on Emissions Requirements
FCA US Reaches Settlements on Emissions Requirements FCA has reached final settlements on civil, environmental and consumer claims with U.S. […]
Brunswick Schedules Fourth Quarter/Full-Year Earnings, Conference Call January 31
Mettawa, Ill., Jan. 10, 2019 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) will release its fourth quarter and full-year 2018 […]
Vishay Intertechnology Releases Commercial IHLP® Inductors Featuring Short Lead Times
MALVERN, Pa., Jan. 10, 2019 (GLOBE NEWSWIRE) — To provide faster access to its most popular IHLP® low profile, high […]
EMA Grants Orphan Drug Designation to Rafael Pharmaceuticals’ devimistat (CPI-613®) for Treatment of Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
Newark, NJ, Jan. 10, 2019 (GLOBE NEWSWIRE) — Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based […]
